Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

CleanCision Wound Retraction and Protection System

N.º K: K172132 · 2017-10-25

SolicitantePrescient Surgical, Inc.
Fecha de decisión2017-10-25
Código de productoPQI
Comité asesorSU
DecisiónSubstantially Equivalent

Resumen del dispositivo

CleanCision Wound Retraction and Protection System is the device name listed in this FDA 510(k) record. The listed applicant is Prescient Surgical, Inc.. It received FDA 510(k) clearance on 2017-10-25 under 510(k) number K172132. The device is classified under product code PQI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the CleanCision Wound Retraction and Protection System?

CleanCision Wound Retraction and Protection System is a medical device that received FDA 510(k) clearance on 2017-10-25. The listed applicant is Prescient Surgical, Inc.. The 510(k) number is K172132.

When did CleanCision Wound Retraction and Protection System receive FDA 510(k) clearance?

CleanCision Wound Retraction and Protection System received FDA 510(k) clearance on 2017-10-25, under 510(k) number K172132.

Who is the listed applicant for CleanCision Wound Retraction and Protection System?

The FDA 510(k) record lists Prescient Surgical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CleanCision Wound Retraction and Protection System?

The FDA product code for CleanCision Wound Retraction and Protection System is PQI.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑